Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience

AIM: To evaluate the effects of insulin degludec/insulin aspart (IDegAsp) coformulation as an intensification of insulin treatment for glycemic control in patients with type 2 diabetes (T2D) in a long term real-world clinical setting. MATERIALS AND METHODS: This retrospective non-interventional stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Oner, Hatice, Gunhan, Hatice Gizem, Gogas Yavuz, Dilek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Clinical Diabetes and Healthcare
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012153/
https://www.ncbi.nlm.nih.gov/pubmed/36992737
http://dx.doi.org/10.3389/fcdhc.2022.783277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012153/
https://www.ncbi.nlm.nih.gov/pubmed/36992737
http://dx.doi.org/10.3389/fcdhc.2022.783277

Ejemplares similares